{
    "2021-02-10": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Why Editas Medicine Stock Sank Today",
                "features": {
                    "keywords": [
                        "Editas",
                        "Medicine",
                        "Stock",
                        "Sank",
                        "Today"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie, Caribou Biosciences Ink Licensing Agreement For (CAR)-T Cell Therapeutics",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Caribou",
                        "Biosciences",
                        "Licensing",
                        "Agreement",
                        "(CAR)-T",
                        "Cell",
                        "Therapeutics"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie and Caribou Biosciences Announce Collaboration and License Agreement for CAR-T Cell Products",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Caribou",
                        "Biosciences",
                        "Collaboration",
                        "License",
                        "Agreement",
                        "CAR-T",
                        "Cell",
                        "Products"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "BOTOX® (onabotulinumtoxinA) Receives FDA Approval for Pediatric Detrusor Overactivity Associated with a Neurologic Condition",
                "features": {
                    "keywords": [
                        "BOTOX®",
                        "FDA",
                        "Approval",
                        "Pediatric",
                        "Detrusor",
                        "Overactivity",
                        "Neurologic",
                        "Condition"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The Zacks Analyst Blog Highlights: Exxon Mobil, AbbVie, Caterpillar, Deere & Co and MetLife",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Exxon",
                        "Mobil",
                        "AbbVie",
                        "Caterpillar",
                        "Deere",
                        "&",
                        "Co",
                        "MetLife"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy",
                        "healthcare",
                        "industrials",
                        "financials"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}